FIELD: medicine.
SUBSTANCE: method involves introducing Detralex at a dose of 500 mg twice a day. No hemorrhages threatening, the grug is introduced in interrupted mode like 30 days receiving the drug and 1 month log pause. Marked gastroenteropathy being the case with hemorrhages threatening, the drug is administered in continuous mode within 2-6 months. Control esopahagoduodenoscopy and endoscopically sclerosing varicose veins of cardia is carried out when indicated. Next, the treatment is continued in interrupted mode. General therapy period is equal to 2-4 years in both groups.
EFFECT: enhanced effectiveness of treatment; no adverse side effects observed; reduced risk of gastrointestinal hemorrhages.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING HYPERSPLENISM AT PERIOD OF CHILDHOOD | 2003 |
|
RU2265407C2 |
| METHOD OF PREDICTING RISK OF HEMORRHAGE FROM GASTRIC VARICES | 2008 |
|
RU2398514C1 |
| METHOD OF ENDOSCOPIC SCLEROTHERAPY OF OESOPHAGUS AND STOMACH VARICOSITY | 2015 |
|
RU2601861C1 |
| METHOD OF ENDOSCOPIC HARDENING OF ESOPHAGEAL VARICOSITY | 2008 |
|
RU2357700C1 |
| METHOD FOR SURGICAL TREATMENT AND PREVENTION OF BLEEDING IN CASE OF VARICOUS EXTENSION OF ESOPHAGUS AND STOMACH VEINS | 2016 |
|
RU2629323C1 |
| METHOD OF MAKING ESOPHAGOGASTROANASTOMOSIS IN PATIENTS WITH PORTAL HYPERTENSION | 2015 |
|
RU2607178C1 |
| METHOD FOR SURGICAL TREATING AND PREVENTING HEMORRHAGES AT VARICOSED ESOPHAGEAL AND GASTRIC VEINS | 2002 |
|
RU2223696C1 |
| METHOD FOR PRIMARY SCLEROGENIC PREVENTIVE HEMOSTASIS AT ESOPHAGUS AND STOMACH VARICOSE VEINS BLEEDING HEIGHT | 2016 |
|
RU2617108C1 |
| RISK PROGNOSIS METHOD FOR VARICOSE VEINS BLEEDING RECURRENCE OF OESOPHAGUS AND STOMACH | 2008 |
|
RU2355287C1 |
| METHOD OF TREATMENT OF HEMORRHAGE IN SYNDROME OF PORTAL HYPERTENSION | 0 |
|
SU1323086A1 |
